postherpetic neuralgia
Conditions
Interventions
dry needling group:conventional therapy + dry needle
placebo-needling group:conventional therapy + placebo needle
Sponsors
The First Affiliated Hospital of Jinan University
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: (1) The diagnosis of postherpetic neuralgia was based on the "Chinese Expert Consensus on the Diagnosis and Treatment of postherpetic neuralgia". (2) Visual analogue scale(VAS) of pain score above 4. (3) No contraindications or intolerable adverse reactions to neuropathic pain drugs, such drugs include: pregabalin, amitriptyline, opioids (tramadol, morphine, oxycodone, etc.). (4) Premenopausal women are willing to confirm birth control measures during the trial. (5) No other treatment will be given during the trial. (6) Have normal comprehension and expression ability.
Exclusion criteria
Exclusion criteria: (1) Patients with other severe chronic pain. (2) Initiate additional treatment during the trial. (3) The patient is pregnant or nursing. (4) Patients with drug or alcohol dependence. (5) Mental illness that affects patients' judgment or interferes with the conduct of the trial. (6) Unwilling to accept the review or unable to understand the scale measurement. (7) Patients with nausea tumor (except patients without recurrence 6 months after radical surgery). (8) Patients with abnormal coagulation function. (9) Patients with acute thrombotic events: ischemic stroke, myocardial infarction, pulmonary embolism, deep venous thrombosis, etc. (10) Unstable angina pectoris. (11) Renal insufficiency (serum creatinine 1.5 times higher than the normal high value). (12) The Investigator considers that there are any conditions that could pose a medical risk or affect the outcome of the trial. (13) Participate in other medical trials during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Short-form McGill Pain questionnaire;the Patient Health Questionnaire-9 (PHQ-9);Short Form-36 Health Survey (SF-36);Pittsburgh Sleep Quality Index (PSQI);Generalized Anxiety Disorder Scale (GAD-7); | — |
Countries
China
Contacts
Public ContactXiaoping Wang
The First Affiliated Hospital of Jinan University
Outcome results
None listed